Suppr超能文献

璞玉浑金:从制剂角度看蛋白质晶体

Diamonds in the rough: protein crystals from a formulation perspective.

作者信息

Jen A, Merkle H P

机构信息

Department of Applied BioSciences, Institute of Pharmaceutical Sciences, ETH Zurich, Switzerland.

出版信息

Pharm Res. 2001 Nov;18(11):1483-8. doi: 10.1023/a:1013057825942.

Abstract

The focus of the present review is to address the use of protein crystals in formulation design. Although this idea has been present for some time, i.e., insulin crystals were first reported back in 1920s, macromolecular crystallization has not received as much attention as the other methods for stabilizing protein drug candidates. The prospective potential of crystalline protein formulations in light of new advances in the field of macromolecular crystallization was reviewed, and the basic concepts and the tools now available for developing protein crystals into drug formulations are introduced. In addition, formulation challenges and regulatory demands, along with examples of current applications of protein crystals, are presented.

摘要

本综述的重点是探讨蛋白质晶体在制剂设计中的应用。尽管这个想法已经存在了一段时间,例如胰岛素晶体早在20世纪20年代就有报道,但大分子结晶并没有像稳定蛋白质候选药物的其他方法那样受到广泛关注。鉴于大分子结晶领域的新进展,对结晶蛋白质制剂的潜在前景进行了综述,并介绍了将蛋白质晶体开发成药物制剂的基本概念和现有工具。此外,还介绍了制剂方面的挑战和监管要求,以及蛋白质晶体当前应用的实例。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验